Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data

Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data

BackgroundTumor mutation burden (TMB) has been recognized as a predictive biomarker for immunotherapy response in cancer. Systematic identification of molecular features correlated with TMB is significant, although such investigation remains insufficient.MethodsWe analyzed associations of somatic mu...

Full description

Bibliographic Details
Main Authors: Mengyuan Li, Xuejiao Gao, Xiaosheng Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Immunology
Subjects:
tumor mutation burden
multi-omics
antitumor immunity
cancer immunotherapy
TMB prognostic score
ceRNA
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1090838/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1090838/full

Similar Items